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DOI: 10.1039/b819688eA multiplexed immunoassay-based antibiotic sensing device integrated in a lab-on-a-chip format is
described. The approach is multidisciplinary and involves the convergent development of a multi-
antibiotic competitive immunoassay based on sensitive wavelength interrogated optical sensor (WIOS)
technology and a polymer-based self-contained microfluidic cartridge. Immunoassay solutions are
pressure-driven through external and concerted actuation of a single syringe pump and multiposition
valve. Moreover, the use of a novel photosensitive material in a ‘one step’ fabrication process allowed
the rapid fabrication of microfluidic components and interconnection port simultaneously. Pre-filled
microfluidic cartridges were used as binary response rapid tests for the simultaneous detection of three
antibiotic families – sulfonamides, fluoroquinolones and tetracyclines – in raw milk. For test
interpretation, any signal lower than the threshold value obtained for the corresponding Maximum
Residue Limit (MRL) concentration (100 mg L1) was considered negative for a given antibiotic. The
reliability of the multiplexed detection system was assessed by way of a validation test carried out on
a series of six blind milk samples. A test accuracy of 95% was calculated from this experiment. The
whole immunoassay procedure is fast (less than 10 minutes) and easy to handle (automated actuation).1. Introduction
The concern for ‘food safety’ surely emerged very early in human
history, contributing to the settlement of certain rules and
customs. Nowadays in technologically developed countries, food
safety is subject to strict legislations that regulate the presence of
undesired substances in food. Focusing on the milk industry,
levels of residues of veterinary medicinal products, of which
antibiotics represent a significant part, are regulated by Euro-
pean Council (EC) Regulation no. 2377/90. More precisely,
a series of four antibiotic families are found to be of particular
interest due to their routine use for treatment in bacterial infec-
tion and/or prophylactic purposes: fluoroquinolones, sulfon-
amides, b-lactams and tetracyclines. The Maximum Residue
Limits (MRLs) determined by the EC concerning those antibi-
otics are 100 mg L1 for fluoroquinolones, sulfonamides, tetra-
cyclines and 4 mg L1 for b-lactams. Their excessive use in dairy
cow diet for the last decades gave rise to stronger bacterial
resistance which consequently represents a serious problem in the
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cols have been developed based on conventional chromato-
graphic techniques such as high performance liquid
chromatography coupled with UV spectroscopy (HPLC-UV)2 or
mass spectrometry (HPLC-MS).3 Despite their efficiency and
high screening capability, those techniques usually require
sample preparation and have to be run by skilled technicians in
a laboratory environment. Further standard test methods used
for antibiotic detection in milk at pasteurizing plants are based
on microbial inhibition assay. Delvotest is one of those tests
commercially available that offer broad spectrum screening
covering all major groups of antibiotic families.4 Similarly,
immunoassay tests for the detection of multiple antibiotics have
been developed based on enzyme-linked immunosorbent assay
(ELISA)5 and parallel affinity sensor array (PASA).6 In spite of
their reliability and high screening capability, those tests have to
be run in a laboratory environment and require at least a few
hours for the assay time.
In this context, one of the major challenges of the dairy
industry for detecting antibiotic residues in milk is the ability to
integrate the quality control analysis in the milk intake process at
the field or farm. In response to the milk industry demand for
rapid and cheap detection protocols, a few tests based on lateral
flow immunochromatography recently appeared on the market.
The key advantage of those strip tests, also known as ‘dipsticks’,
is the easy-to-use protocol where the sample mixed with
immuno-reagents (labeled with colloidal gold or carbon) is
absorption-driven by lateral flow through a nitrocellulose strip.
Typically, those binary response tests are fast (less than 10 min),
easy to perform, cheap, sensitive and specific. A few years ago,
a rapid test in a dipstick format was commercialized for the
simultaneous detection of two families of antibiotics (b-lactams
and tetracyclines).7 However, as far as our knowledge goes, noLab Chip, 2009, 9, 1625–1630 | 1625
rapid detection system has yet been described that is able to
detect in a single operation more than two antibiotics. In this
context, the present work proposes a fully integrated and auto-
mated multi-antibiotic detection system based on the wavelength
interrogated optical sensor (WIOS) technology8 and that is able
to identify the presence in raw milk of sulfonamides, fluo-
roquinolones, and tetracyclines simultaneously. The whole
immunoassay protocol is carried out automatically in the
microfluidic cartridge which is operated by external pump and
valve concerted actuation. Reservoirs for reagent solutions and
sensor chip for WIOS detection are integrated in the microfluidic
cartridge. Unlike conventional techniques such as HPLC,
microbial inhibition assay, ELISA and PASA, the present system
offers a fast, low-cost and easy-to-use test. Moreover, in contrast
to the dipstick format assays, the developed system performs the
detection of at least three antibiotics in a single test.2. Experimental
2.1. Optical transduction principle
The optical detection is based on the recently developed wave-
length interrogated optical sensing (WIOS) approach, the prin-
ciple and instrument details of which have been carefully
reported in previous work.8
The WIOS sensing principle is based on using a collimated
light beam from a vertical cavity surface emitting laser (VCSEL)Fig. 1 Sensing principles of wavelength interrogated optical sensor (WIOS) t
of the WIOS system used are given by the following parameters: dielectric film
groove depth 12 nm. At resonance wavelength a fraction of the incident light is
Output light is collected by plastic optical fibres and analyzed by a photodiode
a biosensing device where the shift in the resonance wavelength reflects the q
1626 | Lab Chip, 2009, 9, 1625–1630as wavelength-tunable source (763 nm  2 nm tuning range) for
exciting waveguide modes in a dielectric waveguide by means of
an input grating coupler (Fig. 1(1)). If the resonance condition is
fulfilled, light is transmitted via an output grating coupler to
a photodetector (Fig. 1(2)). Due to the continuous wavelength
scanning, the output signal of the photodetector represents the
grating coupler resonance peak whose position indicates the
quantity (surface mass density) of analyte molecules adsorbed on
the sensor chip’s surface. The sensing layer can be composed of
recognition molecules like binding proteins, antibodies, DNA
strands or chemical receptors (Fig. 1(3)).The resonant coupling
occurring at the first grating is governed by the grating equation:
lr(t) ¼ L(ne(t)  sinq) (1)
where lr is the resonance wavelength for which coupling occurs,
L the grating period, q the incident angle, and ne(t) the effective
index of the waveguide mode.
For a given optical configuration (q, L fixed), monitoring lr
will give access to effective refractive index variations of the
waveguide mode due to the molecular binding occurring at the
waveguide–bulk interface, as shown in Fig. 1(3).
The grating waveguides have a period of 360 nm and a depth
of 12 nm. The input and output grating coupler have a thickness
of 150 nm and 300 nm, respectively. They are fabricated by a dry
etching technique on the AF45 glass substrate8 and then coated
with a high refractive index layer (Ta2O5 dielectric film). Eachechnology based on grating waveguide resonant coupling. Characteristics
thickness: hin (150 nm), hout (300 nm); grating period: L (360 nm), grating
transmitted into the waveguide and coupled out through the output pad.
detector. Biofunctionalization of the sensing layer converts the WIOS into
uantity of bio-analyte bound.
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sensing chip (17.5 mm  17.5 mm) is constituted of eight indi-
vidual sensing regions (grating pads) allowing simultaneous and
real-time monitoring.Fig. 2 Fabrication process of the LOC cartridge: (a) reservoir plate: (1)
micromilling of PMMA plate for reservoirs and microchannels; (2)
thermal bonding for the sealing of reservoirs and microchannels; (b)
sensor chip with sensing chamber: (1) UV curing of HBP on SU-8
through photomask for the sensing chamber; (2) development of uncured
HBP; (3) bonding of sensing chamber on the grating waveguide chip
using UV adhesive; (c) assembly of the reservoir plate and sensor chip.2.2. Immunoassay formats
Individual and multiplexed competitive immunoassay formats
have been developed using the ELISA approach5 and then
implemented on WIOS technology9 in previous work. The three
assays were performed on indirect formats where specific haptens
for sulfonamides and fluoroquinolones as well as neutravidin
were coated onto different sensing regions (gratings) of the chip.
The chip biofunctionalization was carried out using a poly-
saccharide-based photolinker polymer (OptoDex, Arrayon
Biotechnology) thin-film coating followed by a nanoplotting
technique. The whole immunoassay sequence is composed of
three consecutive steps: milk sample introduction; washing step
and signal amplification using secondary antibody (anti-mouse
and anti-rabbit). Prior to introduction into the fluidic system the
milk to be analyzed was mixed (1 : 5 dilution) with a ‘cocktail’
solution containing the different antiserum receptors that
specifically react with their corresponding antibiotics, if any are
present in the sample. In contact with the sensing surface, the
excess of antibodies (not bound to antibiotics) attached to the
hapten coated on a specific sensing region. After a washing step
the attached antibodies were revealed by reacting with
a secondary antibody. Typically, as for any competitive assay,
the higher the concentration of analyte (a given antibiotic), the
lower the signal obtained, reflecting a low amount of free anti-
body able to attach to the sensing surface. The list of reagents
used for immunoassay is provided in the ESI.†2.3. Microfluidic cartridge fabrication
The microfluidic cartridge consists of two parts: the reservoir
plate and the sensor chip. The reservoir plate is made of the widely
used poly(methyl methacrylate) (PMMA)10–16 where reservoirs
and delivery channels are shaped by micromilling and sealed by
thermal bonding. External dimensions of the cartridge are 100 
40  7 (in millimeters) and the reservoirs exhibit a volume
capacity of around 100 mL. Channels have a rectangular-shaped
section with dimensions of 0.9 mm  0.5 mm. The sensing
chamber is made of a UV-curable hyperbranched polymer (HBP).
The HBP used in this work is an acrylated, third generation pol-
yether core HBP. It combines a high Young’s modulus, a hydro-
philic character and low internal stresses resulting in high
dimensional accuracy.17–19 Alternatively to a previously described
UV molding process for microfluidic devices,20–23 a novel fabri-
cation technique combining UV micromolding and photolithog-
raphy allowed the fabrication of the microfluidic components and
interconnection port simultaneously, as depicted in Fig. 2. Firstly,
a 100 mm thick SU-8 layer was structured by a lithography process
on a silicon substrate. The liquid HBP monomer mixed with
a photoinitiator was dispensed on the SU-8 master and exposed to
UV light for 20 seconds (50 mW cm2) through a Cr photomask
which exhibits patterns of the interconnection port. The control of
the monomer layer thickness was achieved by using spacers
between the SU-8 master and the photomask. Thereafter, the
photomask was removed and the uncured part of the HBP wasThis journal is ª The Royal Society of Chemistry 2009developed using an organic solvent solution. The sensing chamber
was generated on the biofunctionalized sensing chip by bonding
the HBP gasket using UV adhesive. Finally, the sensor chip was
assembled in the reservoir plate and the reservoirs filled with the
different solutions required for the immunoassay. Pictures of the
microfluidic cartridge and HBP gasket are available in the ESI†
(Fig. S1) as well as a list of reagents.2.4. Fluidic setup
Fluidics motion in microfluidic systems has been widely studied
and several strategies are well established in the lab-on-a-chip
field. One of the most elegant approaches is the on-chip electro-
osmotic pump,24,25 particularly convenient for low flow rate
devices (sub mL min1). However, electro-osmotic pumps gener-
ally require a high voltage source (up to kV) and the fabrication
process tends to increase the cost of the microfluidic chip. Alter-
natively, pressure-driven fluidic setups allow easy control of the
flow rate and do not require active channels on the chip. This
approach has been reported regarding a microarray system
actuated by eight syringe pumps for automated analysis of
multiple antibiotics in milk.6 In this work, fluids motion is driven
by a single syringe pump (Cavro XCalibur) working in aspira-
tion mode in combination with a multiposition valve (Cavro
Smart Valve). Both pump and valve are controlled through
PumpLink32 software (Cavro) that allows programming
a sequence of coordinated operations. A picture of the whole
multianalyte detection system is available in the ESI† (Fig S2).
All along the multiplexed immunoassay, the different solutions
pre-contained in the microfluidic cartridge reservoirs have to be
sequentially delivered on the sensing chamber. In the meantime,
the air plug between reservoirs has to be kept away from the
sensing chamber. This is achieved using the coordinatedLab Chip, 2009, 9, 1625–1630 | 1627
Fig. 3 Schematic representation of fluidic setup for sequential liquid
delivery from pre-filled reservoirs to the sensing chamber. The configu-
ration of the microfluidic cartridge during storage is depicted in (1) with
the sensing chamber filled with buffer solution. When the assay begins the
first reservoir starts emptying into loading waste to ensure liquid–liquid
continuity in the junction point (2). Then flow is deviated towards the
sensing chamber (3). The same operation is repeated for liquid contained
in further reservoirs (4) and (5). Through this setup the whole sequence is
controlled by external and concerted actuation of one multiposition valve
connected to atmospheric pressure and one syringe pump (3 ports).
Fig. 4 Photograph sequence showing liquid delivery from reservoirs 1
and 2 to the sensing chamber. (A) Reservoir 1 connected to air: solution
successively delivered to loading waste and sensing chamber. (B) Reser-
voir 2 connected to air: solution 2 driven to loading waste. No residual air
between solutions 1 and 2. (C) Solution 2 driven to sensing chamber. The
arrow in (B) shows the liquid–liquid junction with no residual air going to
the sensing chamber.actuation of pump and valve, together with a loading waste on
the cartridge as described in the schematic representation of
Fig. 3. Waste reservoirs ensure that no residual liquid is going out
of the cartridge, limiting the risk of contamination. The
description of the ‘holder interface’ that ensures cartridge posi-
tioning on the WIOS instrument and connection to the fluidic
functions is detailed in the ESI† (Fig. S3).
Under laminar flow conditions, the reaction rate depends
principally on the analyte concentration leading to higher
stability and reproducibility of the measurement. Regarding the
present system, the hydrodynamic flow generated by negative
pressure actuation through the microfluidic channels and incu-
bation chamber is laminar (flow rate set at 25 mL min1), as
indicated by the very low Reynolds number, Re ¼ 0.85, calcu-




where Q represents the volumetric flow; and dh and n are the
hydrolic diameter and the dynamic viscosity, respectively.1628 | Lab Chip, 2009, 9, 1625–16303. Results and discussion
Prior to immunoassay-based multidetection, the fluidic setup
that includes the microfluidic cartridge and external pump and
valve was successfully evaluated. As shown in Fig. 4, liquid
delivery from the cartridge reservoirs to the sensing chamber is
achieved by controlling the position of the valve which is con-
nected to the air. Moreover, the residual air plug that prevents
solutions mixing between reservoirs during storage is efficiently
maintained out of the sensing chamber during the whole assay
sequence via the so-called loading waste that acts as a flow
diversion path (Fig. 4B). This system design also ensures the
continuous delivery of the sample volume through the sensing
chamber with no air plug between adjacent solutions.
The full assay protocol using the present system consists of
a few simple handling operations: (1) insert the pre-filled
cartridge on the instrument, (2) introduce the milk sample into
the vial, (3) plug the vial onto the instrument, and (4) turn-on the
laser source and run the program for pump/valve control (Fig. S4
in the ESI†).This journal is ª The Royal Society of Chemistry 2009
Fig. 6 WIOS differential response curves corresponding to the ampli-
fication step of the immunoassay obtained for multiplexed detection of
three antibiotics: sulfapyridine (long dashed dot line), ciprofloxacin
(dotted line), and oxytetracycline (dashed line) at MRL concentrations
(100 mg mL1). Those threshold curves define positive and negative test
domains for each antibiotic.Consequently, the automated multiplexed immunoassay takes
place in the sensing chamber and its progress is monitored by the
parallel WIOS signals measured for each antibiotic family. In
order to simplify the typical WIOS response obtained during
multiplexed measurement (one test curve and reference per
antibiotic family) the graph of Fig. 5 represents the WIOS
response curve obtained for a single antibiotic. The immuno-
assay sequence comprises a series of consecutive steps: (1) base-
line stabilization (buffer), (2) milk sample introduction, (3)
washing and (4) introduction of the secondary antibody for
signal amplification. The differential signal value between the test
curve and reference is measured after 10 minutes from the assay
start. Typically for a binary response test the value obtained at
the maximum residue level (MRL) concentration defines two
qualitative domains: for any value inferior or equal to the value
at MRL the test is considered ‘positive’, the remaining domain
being ‘negative’.
On this basis, calibration was carried out for multiplexed
measurement of sulfapyridine (sulfonamide), ciprofloxacin (flu-
oroquinolone) and oxytetracycline (tetracycline) antibiotics in
raw milk. The differential WIOS response corresponding to the
amplification step of the assay and obtained for the multiplexed
detection of three antibiotics at MRL concentrations – that is 100
mg mL1 for each antibiotic – is depicted in Fig. 6. Accordingly to
the competitive format of the immunoassays, those values
measured after a 10 minute assay time are significantly lower
than the ones obtained with a milk sample free of antibiotic, as
shown in Fig. 7. In the case of ciprofloxacin the positive domain
clearly covers a larger response range than the negative one. This
result suggests that the half maximal effective concentration,Fig. 5 Typical WIOS response curve obtained with lab-on-a-chip
immunoassay test where threshold curve obtained at maximum residue
level (MRL) concentration defines positive and negative domains.
Table 1 Test results obtained through the multiplexed blind analysis of six
Sample no.
Sulfonamide Fl
mg L1 Test mg
1 0 
2 100 + 10
3 100 + 5
4 50  10
5 0  5
6 0 
This journal is ª The Royal Society of Chemistry 2009EC50, which corresponds to the part of the sigmoidal calibration
curve with maximal sensitivity is lower than the MRL concen-
tration. However, this occurrence did not represent a limitation
for the sensitive detection of fluoroquinolone in the present
binary test approach. Finally, a validation test was carried out to
evaluate the reliability of the multiplexed test by analyzing six
blind milk samples provided by Nestle. Prior to the test, the
reservoirs of six microfluidic cartridges were pre-filled withFig. 7 Comparative representation of WIOS differential responses
obtained from multiplexed measurements with a milk sample containing
no antibiotic (light grey) and 100 mg L1 (MRL concentration) of sulfa-
pyridine, ciprofloxacin and oxytetracycline (dark grey).
milk samples and the corresponding real antibiotic concentrations
uoroquinolone Tetracycline
L1 Test mg L1 Test
0  0 
0 + 100 +
0  50 
0  50 
0  100 +
0  120 +
Lab Chip, 2009, 9, 1625–1630 | 1629
washing solution and mixture of secondary antibodies; mean-
while, competition reagents were introduced into sample vials.
At this stage the assay protocol previously described was
observed and repeated using one cartridge per sample analyzed.
For each sample, the WIOS differential responses obtained for
each antibiotic family were compared to the corresponding value
at the MRL concentration and converted into a binary response:
a positive or negative test. Afterwards, the test results for the
panel of blind samples were analyzed from the sight of the sample
concentration values revealed by Nestle and summarized in
Table 1. For those three antibiotic families analyzed – sulfon-
amides, fluoroquinolones and tetracyclines – the test accuracy
reached 95% with only one false negative observed for ‘sample 4’
where the MRL concentration of fluoroquinolone was given as
negative. Further experiments are currently being carried out to
implement this multiplexed automated detection system to the b-
lactam antibiotic family.
4. Conclusions
A fully automated lab-on-a-chip system for the simultaneous
detection of multiple antibiotics in raw milk has been developed.
The design and fabrication of a polymer-based microfluidic
cartridge using a combination of micromachining and UV
micromolding with an acrylated HBP make the test cheap, fast
and easy to perform. The disposable and passive self-contained
microfluidic cartridge is externally actuated via a simple fluidic
setup involving a single pump/valve concerted operation. Solu-
tion mixing between reservoirs is prevented by air plugs that are
deviated to loading waste during the assay, resulting in contin-
uous liquid delivery on the sensor chip. The multiplexed auto-
mated immunoassay approach was successfully validated
through the analysis of six blind milk samples containing
sulfonamides, fluoroquinolones and tetracyclines. The test
accuracy reached 95% for multiplexed measurements. The
present a lab-on-a-chip-based detection system that is currently
being implemented to b-lactam antibiotics opens a wide spec-
trum of applications in the fields of food analysis, environment
monitoring and medical diagnosis.
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